ROBIN DAVISSON was named president and CEO-elect of the Melanoma Research Alliance effective Oct. 1.
BROAD INSTITUTE and MD ANDERSON CANCER CENTER were designated the Genome Characterization Centers in a five-year project supported by the NCI to characterize the genomic changes found in tumors.
CHAD MIRKIN was named the inaugural recipient of the Raymond and Beverly Sackler Prize in Convergence Research by the National Academy of Sciences.
TROVAGENE INC. established the Trovagene Research Institute, a European subsidiary focused on expanding the capabilities and adoption of the company's Precision Cancer Monitoring platform. Trovagene has also entered into a collaboration with the Department of Oncology at the University of Torino.
HERBERT FRITSCHE received the 2015 Abbott Award from the International Society of Oncology and Biomarkers for contributions to the field of basic or clinical oncology.
CARLOS ARTEAGA and FREDERICK ALT were named the winners of the 2015 Prize for Scientific Excellence by the American-Italian Cancer Foundation.
JEFFREY LITWIN was named editor-in-chief of the Journal of Clinical Trial Results.
LOIS TRAVIS was named the Lawrence H. Einhorn Professor of Cancer Research at the Indiana University School of Medicine and director of the Cancer Survivorship Research Program at the IU Melvin and Bren Simon Cancer Center.
Jeffrey and W. Kimryn Rathmell appointed to leadership roles at Vanderbilt University Medical Center
JEFFREY RATHMELL and W. KIMRYN RATHMELL were both appointed to leadership roles at Vanderbilt University Medical Center.
MASSIMO CRISTOFANILLI was appointed associate director for precision medicine and translational research at the Robert H. Lurie Comprehensive Cancer Center of Northwestern University and director of Northwestern OncoSET.
